Fluoxetine: A randomized clinical trial in the treatment of obesity

International Journal of Obesity

Volumn 18, Issue 3, 1994, Pages 129-135

  Goldstein, D J ^a   Rampey Jr , A H ^a   Enas, G G ^a   Potvin, J H ^a   Fludzinski, L A ^a   Levine, L R ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Adverse events; Fluoxetine; Obesity; Placebo; Serotonin; Weight reduction

Indexed keywords

FLUOXETINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ALLERGIC REACTION; AMNESIA; ARTICLE; ASTHMA; BODY MASS; BODY WEIGHT; BRONCHITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; NERVOUSNESS; NUTRITION; OBESITY; ORAL DRUG ADMINISTRATION; PATIENT COUNSELING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINITIS; SOMNOLENCE; SWEATING; THIRST; TREMOR; VOMITING; WEIGHT REDUCTION;

ADULT; BODY MASS INDEX; DOUBLE-BLIND METHOD; FEMALE; FLUOXETINE; HUMANS; MALE; MIDDLE AGED; OBESITY; PLACEBOS; WEIGHT LOSS;

EID: 0028222739     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)